Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 55

    Laurus Labs gets 3 USFDA observations for Visakhapatnam facility

    Laurus Labs gets 3 USFDA observations for Visakhapatnam facility

    Medical Dialogues Bureau22 Nov 2019 12:08 PM IST
    The inspection of Visakhapatnam facility in Andhra Pradesh was completed with three observations, 'which are procedural in nature'. No data integrity...
    Zydus Cadila Desonide Cream, Isosorbide Dinitrate tablets get USFDA approval

    Zydus Cadila Desonide Cream, Isosorbide Dinitrate tablets get USFDA approval

    Medical Dialogues Bureau22 Nov 2019 11:55 AM IST
    Zydus Cadila has received approval from the US Food and Drug Administration (USFDA) for Isosorbide Dinitrate tablets for preventing attacks of chest...
    Alnylams rare genetic disorder drug gets early U.S. approval

    Alnylam's rare genetic disorder drug gets early U.S. approval

    Medical Dialogues Bureau21 Nov 2019 12:54 PM IST
    Alnylam Pharmaceuticals Inc on Wednesday received an early U.S. approval for its gene silencing drug to treat patients with a rare genetic disorder...
    Charity to pay $4 million to resolve U.S. pharma kickback probe

    Charity to pay $4 million to resolve U.S. pharma kickback probe

    Medical Dialogues Bureau21 Nov 2019 12:53 PM IST
    BOSTON - A Florida-based charity will pay $4 million to resolve claims that it acted as a conduit for companies including Biogen Inc and Novartis AG...
    China plans to add more drugs to price-slashing bulk-buy program

    China plans to add more drugs to price-slashing bulk-buy program

    Medical Dialogues Bureau21 Nov 2019 12:51 PM IST
    BEIJING: China will add more drugs to its bulk-buy program in an effort to curb high medicine prices, the country's cabinet said, in a move that could...
    Fake doctors, misleading claims drive OxyContin China sales

    Fake doctors, misleading claims drive OxyContin China sales

    Medical Dialogues Bureau21 Nov 2019 12:19 PM IST
    SHANGHAI: The Sackler family's opioid empire in the United States is collapsing under an avalanche of litigation over marketing tactics. Their Purdue...
    China to launch inspection on production, sale, use of illegal African swine fever vaccines

    China to launch inspection on production, sale, use of illegal African swine fever vaccines

    Medical Dialogues Bureau21 Nov 2019 9:00 AM IST
    The ministry has previously warned against the use of such products, after reports of both imported and homemade products being used in China.BEIJING:...
    Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions

    Pfizer Abrilada, biosimilar to Humira gets USFDA nod for multiple inflammatory conditions

    Farhat Nasim20 Nov 2019 12:44 PM IST
    New Delhi: Pfizer Inc. recently announced the United States (U.S.) Food and Drug Administration (USFDA) has approved ABRILADA (adalimumab-afzb), as a...
    FIRST: Dr Reddys forays into nutrition segment with launch of diabetes drink Celevida in India

    FIRST: Dr Reddys forays into nutrition segment with launch of diabetes drink Celevida in India

    Medical Dialogues Bureau20 Nov 2019 12:28 PM IST
    M V Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr Reddy’s Laboratories said, “We are pleased to mark our foray...
    Knowledge sharing from 2019 World Conference on Access to Medical Products to be utilized for larger public welfare: Dr Harsh Vardhan

    Knowledge sharing from 2019 World Conference on Access to Medical Products to be utilized for larger public welfare: Dr Harsh Vardhan

    Medical Dialogues Bureau20 Nov 2019 11:00 AM IST
    The Union Health Minister, Dr Harsh Vardhan stated, “this conference will spur innovative thinking around issues surrounding provisioning of...
    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Medical Dialogues Bureau20 Nov 2019 9:30 AM IST
    Suven Life Sciences provides contract research and manufacturing services to global life sciences companies. It plans to invest 75 million dollars...
    Panacea Biotec appoints Rajeeva Kumar Mangalum as Chief Operating Officer for pharmaceutical operations

    Panacea Biotec appoints Rajeeva Kumar Mangalum as Chief Operating Officer for pharmaceutical operations

    Medical Dialogues Bureau20 Nov 2019 9:15 AM IST
    Panacea Biotec announced the elevation of Rajeeva Kumar Mangalum as Chief Operating Officer for the pharmaceutical operations and Dinesh Singla as...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok